Latin America Pharma

Business

Inventiva's Roller Coaster Ride: Biotech Stock Soars 126% in a Year Amid Volatility and Valuation Debate

French biopharma firm Inventiva (ENXTPA:IVA) has delivered a stunning 126% total return to shareholders over the past year, sharply contrasting with losses over a three-year horizon. As the stock experiences short-term pullbacks, analysts debate whether its current €5.23 price reflects future promise or present hype, with a key drug candidate hanging in the balance.

Jan 30, 2026

World

U.S. and Guatemala Seal Reciprocal Trade Deal, Aiming to Strengthen Western Hemisphere Ties

The United States and Guatemala have formally signed a reciprocal trade agreement designed to dismantle barriers for American exporters and deepen economic integration in the region, officials announced Friday.

Jan 30, 2026

Business

Guggenheim More Than Doubles Erasca Price Target to $12 on Clinical Progress and Pipeline Updates

Erasca Inc. (ERAS) sees its price target raised from $5 to $12 by Guggenheim, following promising clinical data for its lead oncology candidates and updated financial models. The move comes amid a series of positive analyst revisions for the clinical-stage biopharma firm.

Jan 30, 2026

World

Lawsuit Alleges BAT's North Korea Venture Fueled Terror Attacks Against U.S. Forces

A new civil lawsuit accuses British American Tobacco of funneling hundreds of millions to North Korea through a covert joint venture, allegedly financing weapons used in deadly attacks on American personnel in Iraq and Kurdistan.

Jan 30, 2026

Business

Beyond the Chipmakers: The Power Giant Quietly Energizing America's AI Boom

As data center demand surges, NextEra Energy emerges as a critical, and often overlooked, infrastructure player. Its partnerships with tech titans like Meta and Google highlight a strategic pivot in the energy sector.

Jan 30, 2026

Business

Thermo Fisher Scientific Caps 'Strong Year' with Robust Q4, Eyes Strategic Growth Amid Market Headwinds

Thermo Fisher Scientific reported a strong finish to 2025, with Q4 results exceeding expectations. While navigating currency volatility and tariffs, the life sciences giant highlighted growth in core biopharma sectors, strategic acquisitions like Clario, and a solid 2026 outlook.

Jan 30, 2026

Business

Mineralys Therapeutics Submits New Drug Application for Hypertension Treatment Lorundrostat, Backed by Strong Clinical Data

Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.

Jan 30, 2026

Business

UK Watchdog Probes Boots and Superdrug Over 'Misleading' Loyalty Pricing Tactics

A major consumer group has filed a complaint with the Competition and Markets Authority, alleging the pharmacy chains used inflated reference prices to make member discounts appear more substantial than they truly were.

Jan 30, 2026

Business

Corn Market Stumbles into February as Prices Slip Amid Mixed Fundamentals

Corn futures extended their recent slide to start the week, pressured by a stronger dollar and ongoing adjustments in trader positioning. Despite robust export commitments, concerns over South American harvest progress and speculative activity are keeping the market on the back foot.

Feb 2, 2026

Business

From Motor City to Ghost Town: Joe Rogan and Bernie Sanders Decry Detroit's Industrial Collapse

Podcaster Joe Rogan and Senator Bernie Sanders dissect the stark decline of Detroit's auto industry on a recent episode, highlighting abandoned factories, job offshoring, and a city where homes can sell for pennies. The conversation underscores the human cost of deindustrialization and the fierce global competition now facing American automakers.

Feb 2, 2026

Business

U.S. Launches $12 Billion 'Project Vault' to Counter China's Rare Earth Dominance

The White House has confirmed the launch of a major strategic initiative to stockpile rare earth elements, aiming to reduce American dependence on China for the critical minerals used in defense tech and consumer electronics.

Feb 2, 2026

Business

Nova Ltd. (NVMI) Upgraded as Semiconductor Equipment Sector Shows Signs of Robust Recovery

Needham raises Nova Ltd. (NVMI) to Buy with a $500 price target, citing improving industry conditions and the company's strategic position in China's memory market. The upgrade follows a similar bullish move by Bank of America earlier in January.

Feb 2, 2026

Business

Major Banks Pledge to Match Federal 'Baby Bond' Contributions for Employees' Children

JPMorgan Chase, Bank of America, and Wells Fargo announce plans to match a $1,000 government deposit into retirement accounts for children of eligible employees, part of a new national savings initiative.

Feb 2, 2026

As AI Penetrates Patient Care, a Patchwork of State Rules Replaces Federal Guardrails

With pharmaceutical companies increasingly deploying AI in direct-to-consumer platforms, the regulatory landscape remains fragmented. In the absence of comprehensive federal action, states are stepping in with disparate laws to address privacy and safety concerns, creating a complex compliance challenge for the industry.

Feb 2, 2026

Business

Goldman Sachs Raises Dividend, Upgrades 2026 Outlook as Shares Test New Highs

Goldman Sachs Group (GS) has approved a significant dividend increase and projects a robust earnings outlook for Corporate America, fueling debate over whether its strong share price momentum has outpaced its fundamental valuation.

Feb 2, 2026

US

House Committee Advances Contempt Resolutions Against Clintons in Epstein Probe

A House panel is set to vote on referring Bill and Hillary Clinton to the Justice Department for contempt of Congress, escalating a long-running investigation into their connections to the Jeffrey Epstein case.

Feb 2, 2026

The $50K Retirement Blueprint: How Much You Really Need to Save

Achieving a comfortable, $50,000-a-year retirement lifestyle is a common goal for many Americans. We break down the savings target, the critical role of Social Security, and the key factors that can make this financial milestone more attainable.

Feb 2, 2026

Business

Coeur Mining Clears Key Hurdle in $7 Billion New Gold Takeover, Aims for 2026 Completion

A British Columbia court has given its final approval to Coeur Mining's planned acquisition of New Gold, moving the deal that will create a North American precious metals giant one step closer to its expected H1 2026 closing.

Feb 2, 2026

Business

Eli Lilly Bets Nearly $2 Billion on Repertoire Immune Medicines to Pioneer Next-Generation Autoimmune Therapies

Pharmaceutical giant Eli Lilly enters a strategic collaboration potentially worth up to $1.93 billion with biotech firm Repertoire Immune Medicines, aiming to develop precision treatments for autoimmune diseases that move beyond broad immunosuppression.

Feb 2, 2026

Business

BeOne Medicines Deepens InSysBio Modeling Partnership to De-Risk Oncology Pipeline

BeOne Medicines extends its collaboration with quantitative systems pharmacology firm InSysBio, aiming to optimize clinical trial dosing and mitigate cytokine release syndrome risks across its broad portfolio of 15 novel oncology assets.

Feb 2, 2026